Shanghai Kindly Medical Instruments Co., Ltd. Fundamental Analysis
Shanghai Kindly Medical Instruments Co., Ltd. Fundamental Analysis
Shanghai Kindly Medical Instruments Co., Ltd. (1501.HK) shows strong financial fundamentals with a PE ratio of 22.27, profit margin of 20.53%, and ROE of 11.30%. The company generates $1.0B in annual revenue with strong year-over-year growth of 13.17%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 64.6/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze 1501.HK's fundamental strength across five key dimensions:
Efficiency Score
Weak1501.HK struggles to generate sufficient returns from assets.
Valuation Score
Excellent1501.HK trades at attractive valuation levels.
Growth Score
Excellent1501.HK delivers strong and consistent growth momentum.
Financial Health Score
Excellent1501.HK maintains a strong and stable balance sheet.
Profitability Score
Moderate1501.HK maintains healthy but balanced margins.
Key Financial Metrics
Is 1501.HK Expensive or Cheap?
P/E Ratio
1501.HK trades at 22.27 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, 1501.HK's PEG of 1.48 indicates fair valuation.
Price to Book
The market values Shanghai Kindly Medical Instruments Co., Ltd. at 2.44 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 12.81 times EBITDA. This signals the market has high growth expectations.
How Well Does 1501.HK Make Money?
Net Profit Margin
For every $100 in sales, Shanghai Kindly Medical Instruments Co., Ltd. keeps $20.53 as profit after all expenses.
Operating Margin
Core operations generate 25.48 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $11.30 in profit for every $100 of shareholder equity.
ROA
Shanghai Kindly Medical Instruments Co., Ltd. generates $6.98 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Shanghai Kindly Medical Instruments Co., Ltd. generates strong operating cash flow of $325.98M, reflecting robust business health.
Free Cash Flow
Shanghai Kindly Medical Instruments Co., Ltd. generates strong free cash flow of $264.50M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $1.61 in free cash annually.
FCF Yield
1501.HK converts 6.12% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
22.27
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
1.48
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.44
vs 25 benchmark
P/S Ratio
Price to sales ratio
4.31
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.36
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.26
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.11
vs 25 benchmark
ROA
Return on assets percentage
0.07
vs 25 benchmark
ROCE
Return on capital employed
0.12
vs 25 benchmark
How 1501.HK Stacks Against Its Sector Peers
| Metric | 1501.HK Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 22.27 | 29.01 | Better (Cheaper) |
| ROE | 11.30% | 730.00% | Weak |
| Net Margin | 20.53% | -53564.00% (disorted) | Strong |
| Debt/Equity | 0.36 | 0.39 | Neutral |
| Current Ratio | 1.26 | 4.47 | Neutral |
| ROA | 6.98% | -18932.00% (disorted) | Weak |
1501.HK outperforms its industry in 2 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Shanghai Kindly Medical Instruments Co., Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
115.90%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
39.85%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
77.81%
Industry Style: Defensive, Growth, Innovation
High Growth